SEARCH

SEARCH BY CITATION

References

  • 1
    Alvarez F, Berg PA, Bianchi FB et al. International Autoimmune Hepatitis Group Report: Review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999; 31: 929938.
  • 2
    Gregorio G, Portmann B, Reid F et al. Autoimmune hepatitis in childhood: A 20-year experience. Hepatology 1997; 25: 541547.
  • 3
    Kerkar N, Hadzic N, Davies ET et al. De-novo autoimmune hepatitis after liver transplantation. Lancet 1998; 351: 409413.
  • 4
    Andries S, Casamayou L, Sempoux C et al. Posttransplant immune hepatitis in pediatric liver transplant recipients: Incidence and maintenance therapy with azathioprine. Transplantation 2001; 72: 267272.
  • 5
    Hernandez H, Kovarik P, Whitington P et al. Autoimmune hepatitis as a late complication of liver transplantation. J Pediatr Gastroenterol Nutr 2001; 32: 131136.
  • 6
    Gupta P, Hart J, Millis J et al. De novo hepatitis with autoimmune autoantibodies and atypical histology. Transplantation 2001; 71: 664668.
  • 7
    Spada M, Bertani A, Sonzogni A et al. A cause of late graft dysfunction after liver transplantation in children: De-novo autoimmune hepatitis. Transplant Proc 2001; 33: 17471748.
  • 8
    Miyagawa-Hayashino A, Haga H, Egawa H et al. Outcome and risk factors of de novo autoimmune hepatitis in living-donor liver transplantation. Transplantation 2004; 78: 128135.
  • 9
    Hadzic N, Srinivasan R, Rela M et al. De novo autoimmune hepatitis after liver transplantation in children: A single centre experience [abstract]. Hepatology 2003; 38: 202A.
  • 10
    Mieli-Vergani G, Vergani D. Autoimmune hepatitis in children. Clin Liver Dis 2002; 6: 623634.
  • 11
    Petz W, Sonzogni A, Bertani A et al. A cause of late graft dysfunction after pediatric liver transplantation. Transplant Proc 2002; 34: 19581959.
  • 12
    Jankowska I, Pawlowska J, Teisseyre M et al. Autoimmune hepatitis in transplanted liver. Transplant Proc 2004; 36: 30773082.
  • 13
    Jones DE, James OF, Portmann B et al. Development of autoimmune hepatitis following liver transplantation for primary biliary cirrhosis. Hepatology 1999; 30: 5357.
  • 14
    Heneghan MA, Portmann BC, Norris SM et al. Graft dysfunction mimicking autoimmune hepatitis following liver transplantation in adults. Hepatology 2001; 34: 464470.
  • 15
    Salcedo M, Vaquero J, Banares R et al. Response to steroids in de novo autoimmune hepatitis after liver transplantation. Hepatology 2002; 35: 349356.
  • 16
    Aguilera I, Wichmann I, Sousa JM et al. Antibodies against glutathione S-transferase T1 (GSTT1) in patients with de novo immune hepatitis following liver transplantation. Clin Exp Immunol 2001; 126: 535539.
  • 17
    Mieli-Vergani G, Vergani D. De novo autoimmune hepatitis after liver transplantation. J Hepatol 2004; 40: 37.
  • 18
    Clemente MG, Vaijro P, Musu M et al. Autoimmune manifestations in children transplanted for non-autoimmune liver diseases [abstract]. J Hepatol 2001; 34: 45.
  • 19
    Vergani D, Mieli-Vergani G. Autoimmunity after liver transplantation. In: GershwinME, VierlingJ, MannsM, eds. Liver Immunology. Philadelphia : Hanley and Belfus, 2003:469479.
  • 20
    Salcedo M, Pons JA, Sousa JM et al. De novo autoimmune hepatitis after liver transplantation [abstract]. J Hepatol 2001; 34: 49.
  • 21
    Saxena R, Sukma M, Kim-Schulger L, Shneider B, Emre S, Thung SN. Post transplant autoimmune hepatitis [abstract]. Hepatology 2001; 34: 292.
  • 22
    Conti F, Dousset B, Levillayer H et al. Autoantibodies after liver transplantation: A marker of allograft disease [abstract]. J Hepatol 1997; 26: 150.
  • 23
    McDiarmid SV, Farmer DA, Goldstein LI et al. A randomized prospective trial of steroid withdrawal after liver transplantation. Transplantation 1995; 60: 14431450.
  • 24
    McDiarmid SV, Anand R, Lindblad AS, SPLIT Research Group. Studies of pediatric liver transplantation: 2002 Update. An overview of demographics, indications, timing, and immunosuppressive practices in pediatric liver transplantation in the United States and Canada. Pediatr Transplant 2004; 8: 284294.
  • 25
    European Liver Transplant Registry. Available at: http://www.eltr.org; accessed March 20, 2006.
  • 26
    Chinnakotla S, Klintmalm GB. Induction and maintenance of immunosuppression. In: BusuttilRW, KlintmalmGB, eds. Transplantation of the Liver, 2nd Ed. Philadelphia , PA : Elsevier Saunders, 2005:12131234.
  • 27
    Salcedo M, Vaquero J, Baneres R et al. Serum autoantibodies after liver transplantation. Prevalence and associated immunologic disorders [abstract]. J Hepatol 2001; 34: 47.
  • 28
    Hernandez-Albujar A, Alvarez E, Salcedo M et al. Autoimmune mediated liver disease after liver transplantation [abstract]. J Hepatol 1997; 26: 152.
  • 29
    Rong PB, Kalsi J, Hodgson HJ. Hyperglobulinaemia in chronic liver disease: Relationships between in vitro immunoglobulin synthesis, short lived suppressor cell activity and serum immunoglobulin levels. Clin Exp Immunol 1984; 55: 546552.
  • 30
    Husby G, Skrede S, Blomhoff JP et al. Serum immunoglobulins and organ non-specific antibodies in diseases of the liver. Scand J Gastroenterol 1977; 12: 297304.
  • 31
    Doron S, Ruthazer R, Werner BG et al. Hypogammaglobulinemia in liver transplant recipients: Incidence, timing, risk factors, and outcomes. Transplantation 2006; 81: 697703.
  • 32
    Vergani D, Mieli-Vergani G. Mechanisms of autoimmune hepatitis. Pediatr Transplant 2004; 8: 589593.
  • 33
    Dubel L, Farges O, Johanet C et al. High incidence of antitissue antibodies in patients experiencing chronic liver allograft rejection. Transplantation 1998; 65: 10721075.
  • 34
    Czaja AJ. Drug therapy in the management of type 1 autoimmune hepatitis. Drugs 1999; 57: 4968.
  • 35
    Gao E, Lo D, Cheney R et al. Abnormal differentiation of thymocytes in mice treated with cyclosporine A. Nature 1988; 336: 176179.
  • 36
    Jenkins MK, Schwartz RH, Pardoll DM. Effects of cyclosporine A on T cell development and clonal deletion. Science 1988; 241: 16551658.
  • 37
    Bucy PB, Yan Xu X, Li J, Huang GQ. Cyclosporine A-induced autoimmune disease in mice. J Immunol 1993; 151: 10391050.
  • 38
    Czaja AJ. Autoimmune hepatitis after liver transplantation and other lessons of self-intolerance. Liver Transpl 2002; 8: 505513.
  • 39
    Bogdanos DP, Choudhuri K, Vergani D. Molecular mimicry and autoimmune liver disease: Virtuous intentions, malign concerns. Liver 2001; 21: 225232.
  • 40
    Aguilera I, Sousa J, Gavilan F et al. Glutathione S-transferase T1 mismatch constitutes a risk factor for de-novo immune hepatitis after liver transplantation. Liver Transpl 2004; 10: 11661172.
  • 41
    Fedoseyeva EV, Tam RC, Popov IA, Orr PL, Garovoy MR, Benichou G. Induction of T cell responses to a self-antigen following allotransplantation. Transplantation 1996; 61: 679683.
  • 42
    Fedoseyeva EV, Zhang F, Orr PL, Levin D, Buncke HJ, Benichou G. De novo autoimmunity to cardiac myosin after heart transplantation and its contribution to the rejection process. J Immunol 1999; 162: 68366842.
  • 43
    Miyagawa-Hayashino A, Haga H, Sakurai T, Shirase T, Manabe T, Egawa H. De novo autoimmune hepatitis affecting allograft but not the native liver in auxiliary partial orthotopic liver transplantation. Transplantation 2003; 76: 271272.